Dr Reddys Financial Indicators Patterns

RDY -- USA Stock  

USD 40.63  0.21  0.52%

Use fundamental data analysis to check all available fundamental indicators of Dr Reddys Laboratories to find out if markets are right now mispricing the company. We found thirty-six available financial indicators for Dr Reddys which can be compared to its peers in the sector. To make sure the equity is not overpriced, please confirm all Dr Reddys Laboratories Ltd fundamentals including its Number of Shares Shorted, Current Ratio, Current Asset, as well as the relationship between EBITDA and Number of Employees . Given that Dr Reddys Laboratories has Price to Book of 3.45 , we urge you verify Dr Reddys latest market performance to make sure the company can sustain itself in the future. Use Dr Reddys to enhance returns of your portfolios. The stock experiences moderate upward volatility. Check odds of Dr Reddys to be traded at $44.69 in 30 days.
12%12%

Chance of Financial Distress

Dr Reddys Laboratories Ltd has less than 12 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Dr Reddys Company Summary

Dr Reddys competes with Vertex Pharmaceuticals, Zoetis, Perrigo Company, and Regeneron Pharmaceuticals. Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.

Dr Reddys Cash and Equivalents vs Number of Shares Shorted

Dr Reddys Laboratories Ltd is rated below average in cash and equivalents category among related companies. It is rated below average in number of shares shorted category among related companies making about  0.01  of Number of Shares Shorted per Cash and Equivalents. The ratio of Cash and Equivalents to Number of Shares Shorted for Dr Reddys Laboratories Ltd is roughly  177.13 

Dr Reddys Laboratories Systematic Risk

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Dr Reddys Laboratories correlated with the market. If Beta is less than 0 Dr Reddys generally moves in the opposite direction as compared to the market. If Dr Reddys Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dr Reddys Laboratories is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dr Reddys is generally in the same direction as the market. If Beta > 1 Dr Reddys moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Dr Reddys Thematic Clasifications

Obamacare Idea
ObamacareView

Dr Reddys December 9, 2019 Opportunity Range

Additionally take a look at Your Equity Center. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com